GenShare: Sharing Accurate Differentially-Private Statistics for Genomic Datasets with Dependent Tuples

Nour Almadhoun Alserr; Ozgur Ulusoy; Erman Ayday; Onur Mutlu

Home/Archive/arXiv

arXiv · 2112.15109

GenShare: Sharing Accurate Differentially-Private Statistics for Genomic Datasets with Dependent Tuples

Nour Almadhoun Alserr·Ozgur Ulusoy·Erman Ayday·Onur Mutlu

View original source ↗Read source document ↗Export metadata ↓

Abstract

Motivation: Cutting the cost of DNA sequencing technology led to a quantum leap in the availability of genomic data. While sharing genomic data across researchers is an essential driver of advances in health and biomedical research, the sharing process is often infeasible due to data privacy concerns. Differential privacy is one of the rigorous mechanisms utilized to facilitate the sharing of aggregate statistics from genomic datasets without disclosing any private individual-level data. However, differential privacy can still divulge sensitive information about the dataset participants due to the correlation between dataset tuples. Results: Here, we propose GenShare model built upon Laplace-perturbation-mechanism-based DP to introduce a privacy-preserving query-answering sharing model for statistical genomic datasets that include dependency due to the inherent correlations between genomes of individuals (i.e., family ties). We demonstrate our privacy improvement over the state-of-the-art approaches for a range of practical queries including cohort discovery, minor allele frequency, and chi^2 association tests. With a fine-grained analysis of sensitivity in the Laplace perturbation mechanism and considering joint distributions, GenShare results near-achieve the formal privacy guarantees permitted by the theory of differential privacy as the queries that computed over independent tuples (only up to 6% differences). GenShare ensures that query results are as accurate as theoretically guaranteed by differential privacy. For empowering the advances in different scientific and medical research areas, GenShare presents a path toward an interactive genomic data sharing system when the datasets include participants with familial relationships.

Explore related subjects

q-bio.GN cs.CR

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Nour Almadhoun Alserr, Ozgur Ulusoy, Erman Ayday, Onur Mutlu. 2021-12-30. GenShare: Sharing Accurate Differentially-Private Statistics for Genomic Datasets with Dependent Tuples. https://arxiv.org/abs/2112.15109

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; yet substantial proportion of patients exhibit intrinsic or acquired resistance, making accurate pre-treatment response prediction a critical unmet need. Transcriptomics-based biomarkers derived from bulk and single-cell RNA sequencing (scRNA-seq) offer a promising avenue for capturing tumour-immune interactions, yet the cross-cohort generalisability of existing prediction models remains unclear.We systematically benchmark nine state-of-the-art transcriptomic ICI response predictors, five bulk RNA-seq-based models (COMPASS, IRNet, NetBio, IKCScore, and TNBC-ICI) and four scRNA-seq-based models (PRECISE, DeepGeneX, Tres and scCURE), using publicly available independent datasets unseen during model development. Overall, predictive performance was modest: bulk RNA-seq models performed at or near chance level across most cohorts, while scRNA-seq models showed only marginal improvements. Pathway-level analyses revealed sparse and inconsistent biomarker signals across models. Although scRNA-seq-based predictors converged on immune-related programs such as allograft rejection, bulk RNA-seq-based models exhibited little reproducible overlap. PRECISE and NetBio identified the most coherent immune-related themes, whereas IRNet predominantly captured metabolic pathways weakly aligned with ICI biology. Together, these findings demonstrate the limited cross-cohort robustness and biological consistency of current transcriptomic ICI prediction models, underscoring the need for improved domain adaptation, standardised preprocessing, and biologically grounded model design.

q-bio.GN↗

arXiv2026

Large Language Model Agents for Evidence Based Genetic Disease Severity Classification

Disease severity classification for genetic conditions is subjective and labor-intensive, creating bottlenecks in genomic screening, where commercial panels vary widely in size and overlap. We developed an autonomous AI agent integrating Reasoning and Acting (ReAct) with Retrieval-Augmented Generation (RAG) to classify 10,211 Human Phenotype Ontology terms. It uses American College of Medical Genetics (ACMG)-endorsed severity guidelines and American College of Obstetricians and Gynecologists (ACOG) quality-of-life criteria to retrieve PubMed literature, generate interpretable reasoning chains, and independently verify claims. At the phenotype level, using expert-curated cohorts, the agent achieved 93.55% accuracy (MCC 0.9237) with 82.6% to 91.4% of claims supported by direct evidence or valid inferences. Gene-level severity was aggregated across 8,738 pairs, identifying 3,283 autosomal recessive pairs with severe or profound presentations. External validation showed 95.2% concordance with Mackenzie's Mission gene list. This system enables standardized panel design by providing reliable, automated classification supported by direct evidence.

q-bio.GN↗

arXiv2026

Harmonised benchmarking of foundation models for single-cell and spatial transcriptomics reveals context-dependent generalisation

Single-cell and spatial foundation models promise transferable biological representations, yet their generality remains largely untested across modalities, biological domains and analytical tasks. We benchmarked six representative models, Nicheformer, CellPLM, scGPT-spatial, GenePT, scELMo and Novae, using a harmonised framework spanning scRNA-seq, spatial transcriptomics and Perturb-seq. We evaluated zero-shot and continually pretrained clustering, supervised annotation, marker-gene concordance and perturbation prediction. Model performance was strongly conditional: expression-trained cell-level transformers best resolved many cell-identity tasks, spatial and graph-aware models better preserved tissue architecture, and language-derived gene embeddings were competitive for selected perturbation-response metrics. No model dominated across tasks, and rankings shifted with modality, preprocessing, tokenisation, biological prior, domain shift and metric choice. This benchmark provides practical guidance for model selection and argues that future models should be judged by biological generalisation, interpretability and perturbation-grounded validity, not by scale or leaderboard performance alone.

q-bio.GN↗